Methotrexate and bone marrow suppression: drug errors may be implicated in death.
作者信息
Grove Matthew L
出版信息
BMJ. 2003 May 24;326(7399):1145; author reply 1145-6. doi: 10.1136/bmj.326.7399.1145-b.
Abstract
摘要
相似文献
1
Methotrexate and bone marrow suppression: drug errors may be implicated in death.
BMJ. 2003 May 24;326(7399):1145; author reply 1145-6. doi: 10.1136/bmj.326.7399.1145-b.
2
Methotrexate and bone marrow suppression: standard collaborative care will be made more difficult.
BMJ. 2003 May 24;326(7399):1145; author reply 1145-6. doi: 10.1136/bmj.326.7399.1145-c.
3
Reducing methotrexate errors.
Geriatr Nurs. 2010 Sep-Oct;31(5):361-4. doi: 10.1016/j.gerinurse.2010.08.002. Epub 2010 Sep 15.
4
Low dose methotrexate and bone marrow suppression.
BMJ. 2003 Feb 1;326(7383):266-7. doi: 10.1136/bmj.326.7383.266.
5
Methotrexate deaths prompt warning and new guidelines.
Nurs Times. 2004;100(32):8.
6
[Treatment of chronic polyarthritis with methotrexate 1994--a review].
Z Rheumatol. 1994 Jul-Aug;53(4):199-229.
7
[Ulcerative stomatitis as clinical clue to inadvertent methotrexate overdose].
Hautarzt. 1999 Sep;50(9):670-3. doi: 10.1007/s001050050979.
8
Bone marrow gold.
Br J Haematol. 2012 Jan;156(2):153. doi: 10.1111/j.1365-2141.2011.08856.x. Epub 2011 Nov 7.
9
[Methotrexate: mainstay of rheumatoid arthritis treatment].
Ned Tijdschr Geneeskd. 2009;153:A879.
10
Methods to enhance the safety of methotrexate prescribing.
J Clin Pharm Ther. 2007 Aug;32(4):327-31. doi: 10.1111/j.1365-2710.2007.00834.x.
本文引用的文献
1
Low dose methotrexate and bone marrow suppression.
BMJ. 2003 Feb 1;326(7383):266-7. doi: 10.1136/bmj.326.7383.266.
2
Adverse reactions to disease-modifying anti-rheumatic drugs in clinical practice.
QJM. 2001 Jun;94(6):309-19. doi: 10.1093/qjmed/94.6.309.
3
Clinical pharmacokinetics of low-dose pulse methotrexate in rheumatoid arthritis.
Clin Pharmacokinet. 1996 Mar;30(3):194-210. doi: 10.2165/00003088-199630030-00002.
Zotero 插件